ZHANG, Shutong. Aducanumab and Lecanemab: Target Specificity, Mechanisms and Clinical Outcomes in Alzheimer’s Disease. MedScien, [S. l.], v. 4, n. 4, p. 7302, 2026. DOI: 10.61173/yhcven77. Disponível em: https://ms.deanfrancis.press/article/view/78. Acesso em: 24 oct. 2026.